THE BLOG
the patented medicines review board has lost its way (again)
this article was originally published on the macdonald laurier laurier institute blog by W. Neil Palmer on November 1.2022 and republished here. The Patented Medicine Prices Review Board (PMPRB) is once again attracting the ire of the life sciences industry and...
open letter: let’s put cancer at the top of the agenda
as the ministers of health across the country meet in vancouver over the next couple of days, the CANCER ACTION NOW ALLIANCE members have drafted a letter to remind them of the canadians, who every day are diagnosed, treated, screened and die from cancer. an ongoing...
Cancer deaths must not be a side effect of the pandemic: delays in cancer diagnosis and treatment could cause thousands to suffer and die prematurely
Pandemic-related delays to screening, treatment, and surgeries have created a backlog of cancer patients needing more support, at more advanced stages of cancer TORONTO, May 24, 2022 /CNW/ - The pandemic has brought our cancer care systems to a crisis point...
when to talk to your healthcare team about biomarker testing
because not all tumours behave the same way, biomarkers can provide information about the molecular characteristics of a tumour creating a personalized approach to treating cancer. knowing your biomarker status can determine if targeted therapies are right for you and...
why precision medicine matters
when we talk about mutations, this represents a very small amount of cancer patients - in colorectal cancer for example, mutations in NTRK, MSI-h/dMMR, and BRAF are considered rare [1%, 15%, 9% respectively]. however, this actually represents respectively-...
colorectal cancer canada survey results on molecular profiling in canada
@coloncanada through their GET PERSONAL program launched a two phase project- the first phase of the project included a The first phase of the project included a pan-tumour, pan-canadian survey that was sent to multi-disciplinary healthcare professionals aimed to...